terminalia bellerica fruit water

aqueous solution of the steam distillate obtained from the fruit of the terminalia bellerica, combretaceae

CAS: 92202-43-2

Identification

Nameterminalia bellerica fruit water
IUPACterminalia bellerica fruit water
CAS Number92202-43-2
FDA UNIISearch

Regulatory

Physical Properties

Food Chemicals Codex Listed No

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesskin conditioning

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorycosmetic ingredient for skin conditioning
Recommendation for terminalia bellerica fruit water usage levels up tonot for fragrance use.
Recommendation for terminalia bellerica fruit water flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

None Found

Natural Occurrence

terminalia bellerica fruit

Synonyms

aqueous solution of the steam distillate obtained from the fruit of the terminalia bellerica, combretaceae bibitaki fruit water myrobalanus bellirica fruit water myrobalanus laurinoides fruit water terminalia attenuata fruit water terminalia bellirica fruit water terminalia bellirica var. laurinoides fruit water terminalia eglandulosa fruit water terminalia gella fruit water terminalia laurinoides fruit water terminalia punctata fruit water PubMed: Constituents from Terminalia species increase PPARα and PPARγ levels and stimulate glucose uptake without enhancing adipocyte differentiation. PubMed: Therapeutic potential of octyl gallate isolated from fruits of Terminalia bellerica in streptozotocin-induced diabetic rats. PubMed: Acute and chronic toxicity studies of the water extract from dried fruits of Terminalia bellerica (Gaertn.) Roxb. In Spargue-Dawley rats. PubMed: Antinociceptive activity of chronic administration of different extracts of Terminalia bellerica Roxb. and Terminalia chebula Retz. fruits. PubMed: Quantification of gallic acidin fruits of three medicinal plants. PubMed: In vitro and in vivo antiplasmodial activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula, and Terminalia bellerica. PubMed: In vitro antioxidant activities of the methanol extract and its different solvent fractions obtained from the fruit pericarp of Terminalia bellerica. PubMed: Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats. PubMed: Antioxidant activity of acetone extract/fractions of Terminalia bellerica Roxb. fruit. PubMed: Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrida): characterization, quantitation and determination of antioxidant capacities. PubMed: Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits. PubMed: Mechanisms underlying the antispasmodic and bronchodilatory properties of Terminalia bellerica fruit. PubMed: Phenolic contents and antioxidant activity of some food and medicinal plants. PubMed: Bioassay-guided isolation of antimutagenic factors from fruits of Terminalia bellerica. PubMed: Indian medicinal plants as a reservoir of protective phytochemicals. PubMed: Effect of gamma radiation and different packings used for storage of the drug bahera fruit (terminalia bellerica roxb) on microflora population (fungi, pathogenic bacterial sp & spc) and on the phytoconstituents (protein and tannin). PubMed: Modern drug development from traditional medicinal plants using radioligand receptor-binding assays. PubMed: New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. PubMed: Antimutagenic effects of polyphenols isolated from Terminalia bellerica myroblan in Salmonella typhimurium. PubMed: Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase.